Immuneel Therapeutics Pvt. Ltd.

Immuneel Therapeutics Pvt. Ltd. company information, Employees & Contact Information

A pioneering clinical stage startup company leading the Cell & Gene therapy revolution and are committed to bringing breakthrough cancer treatment to patients in India, making it accessible & affordable.

Company Details

Employees
91
Founded
-
Address
29/p2, 8th Floor, A-Block Mazumdar Shaw Medical Center Narayana Hrudayalaya Health City, Hosur Road 258/a,bommasandra Industrial Area Anekal Taluk,india
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Bengaluru, Karnataka
Looking for a particular Immuneel Therapeutics Pvt. Ltd. employee's phone or email?

Immuneel Therapeutics Pvt. Ltd. Questions

News

ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics - PR Newswire

ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics PR Newswire

ScaleReady awards $150,000 grant to Immuneel Therapeutics - BioSpectrum India

ScaleReady awards $150,000 grant to Immuneel Therapeutics BioSpectrum India

Immuneel Therapeutics launches Qartemi, a CAR T-cell therapy for Non-Hodgkin’s Lymphoma - Express Pharma

Immuneel Therapeutics launches Qartemi, a CAR T-cell therapy for Non-Hodgkin’s Lymphoma Express Pharma

Cell & gene therapy statrtup Immuneel unveils CAR-T cancer therapy in India - Business Standard

Cell & gene therapy statrtup Immuneel unveils CAR-T cancer therapy in India Business Standard

Kiran Mazumdar Shaw-backed Immuneel rolls out CAR-T cancer therapy today - Mint

Kiran Mazumdar Shaw-backed Immuneel rolls out CAR-T cancer therapy today Mint

Immuneel’s internationally-benchmarked CAR-T cell therapy for Non-Hodgkin’s Lymphoma, is one-tenth US cost: CEO - BusinessLine

Immuneel’s internationally-benchmarked CAR-T cell therapy for Non-Hodgkin’s Lymphoma, is one-tenth US cost: CEO BusinessLine

Immuneel Therapeutics launches CAR T-cell therapy for blood cancer in India - financialexpress.com

Immuneel Therapeutics launches CAR T-cell therapy for blood cancer in India financialexpress.com

taiba Make Strategic Investment in Immuneel Therapeutics to advance CAR T-cell Research and Make Therapies More Affordable. - Business Wire

taiba Make Strategic Investment in Immuneel Therapeutics to advance CAR T-cell Research and Make Therapies More Affordable. Business Wire

Immuneel Therapeutics Raises INR 100 Cr to Expand Cancer Therapy Innovations - Entrepreneur

Immuneel Therapeutics Raises INR 100 Cr to Expand Cancer Therapy Innovations Entrepreneur

Kiran Mazumdar-Shaw’s Immuneel Therapeutics Bags INR 100 Cr To Expand Operations - Inc42

Kiran Mazumdar-Shaw’s Immuneel Therapeutics Bags INR 100 Cr To Expand Operations Inc42

Immuneel Therapeutics raises $15M and starts patient trials for CAR-T cancer therapies - Labiotech.eu

Immuneel Therapeutics raises $15M and starts patient trials for CAR-T cancer therapies Labiotech.eu

Hospital Clínic-IDIBAPS and Immuneel Therapeutics announce a strategic collaboration to improve - Hospital Clínic Barcelona

Hospital Clínic-IDIBAPS and Immuneel Therapeutics announce a strategic collaboration to improve Hospital Clínic Barcelona

Immuneel Therapeutics unveils India’s first global CAR T-cell therapy for Non-Hodgkin’s Lymphoma - BioSpectrum India

Immuneel Therapeutics unveils India’s first global CAR T-cell therapy for Non-Hodgkin’s Lymphoma BioSpectrum India

Immuneel Therapeutics raises $15 million in funding - The Economic Times

Immuneel Therapeutics raises $15 million in funding The Economic Times

Biotech startup Immuneel Therapeutics raises Rs 100 Cr in Series A round extension - YourStory.com

Biotech startup Immuneel Therapeutics raises Rs 100 Cr in Series A round extension YourStory.com

Cancer and a bespoke therapy: Immuneel Therapeutics COO Dr Arun Anand weighs in - Moneycontrol

Cancer and a bespoke therapy: Immuneel Therapeutics COO Dr Arun Anand weighs in Moneycontrol

Exclusive: Kiran Mazumdar Shaw’s Immuneel Therapeutics raises Rs 100 Cr - Entrackr

Exclusive: Kiran Mazumdar Shaw’s Immuneel Therapeutics raises Rs 100 Cr Entrackr

Kiran Mazumdar-Shaw co-founded biotech startup raises $15 mn in Series A funding - Mint

Kiran Mazumdar-Shaw co-founded biotech startup raises $15 mn in Series A funding Mint

Immuneel's CAR-T cell therapy reports positive in early phase-2 trials in India - The Economic Times

Immuneel's CAR-T cell therapy reports positive in early phase-2 trials in India The Economic Times

Kiran Mazumdar Shaw’s Immuneel Therapeutics raises Rs 100 crore in funding - Indian Startup News

Kiran Mazumdar Shaw’s Immuneel Therapeutics raises Rs 100 crore in funding Indian Startup News

[Funding alert] Biotech startup Immuneel Therapeutics raises $15M in Series A round - YourStory.com

[Funding alert] Biotech startup Immuneel Therapeutics raises $15M in Series A round YourStory.com

Cell therapy cancer centre takes shape in Bengaluru, trials are on - The Indian Express

Cell therapy cancer centre takes shape in Bengaluru, trials are on The Indian Express

Amit Mookim steps in as CEO of Immuneel Therapeutics - BioSpectrum India

Amit Mookim steps in as CEO of Immuneel Therapeutics BioSpectrum India

Immuneel Therapeutics welcomes Amit Mookim as CEO - Express Pharma

Immuneel Therapeutics welcomes Amit Mookim as CEO Express Pharma

Immuneel Therapeutics appoints Amit Mookim as CEO - Pharmabiz.com

Immuneel Therapeutics appoints Amit Mookim as CEO Pharmabiz.com

Aiming for sustainable innovation with affordable CAR-T therapy in India: Arun Anand, COO, Immuneel Therapeutics - Moneycontrol

Aiming for sustainable innovation with affordable CAR-T therapy in India: Arun Anand, COO, Immuneel Therapeutics Moneycontrol

Scaling CAR-T for India: How ScaleReady’s G-Rex grant is empowering Immuneel Therapeutic - BioSpectrum India

Scaling CAR-T for India: How ScaleReady’s G-Rex grant is empowering Immuneel Therapeutic BioSpectrum India

Immuneel to offer affordable cell and gene therapy for cancer patients in India - Express Pharma

Immuneel to offer affordable cell and gene therapy for cancer patients in India Express Pharma

Join Immuneel Therapeutics as a Downstream Process Development Scientist, Apply Now! - BioTecNika

Join Immuneel Therapeutics as a Downstream Process Development Scientist, Apply Now! BioTecNika

Immuneel Therapeutics Launches India’s First CAR T-cell Therapy for Non-Hodgkin’s Lymphoma - Digital Health News

Immuneel Therapeutics Launches India’s First CAR T-cell Therapy for Non-Hodgkin’s Lymphoma Digital Health News

Immuneel acquires exclusive license to CD19 CAR T Product for the Potential Treatment of B Cell Malignancies for India - BW Healthcare World

Immuneel acquires exclusive license to CD19 CAR T Product for the Potential Treatment of B Cell Malignancies for India BW Healthcare World

Kiran Mazumdar Shaw's Co-Founded Immuneel Therapeutics Secures $15 Mn Funding - BW Businessworld

Kiran Mazumdar Shaw's Co-Founded Immuneel Therapeutics Secures $15 Mn Funding BW Businessworld

Immuneel Therapeutics began patient dosing in a CAR-T trial named "IMAGINE" - Healthcare Radius

Immuneel Therapeutics began patient dosing in a CAR-T trial named "IMAGINE" Healthcare Radius

Immuneel sets up cell therapy development and production facility in Narayana Hrudayalaya Health City, Bengaluru - Express Pharma

Immuneel sets up cell therapy development and production facility in Narayana Hrudayalaya Health City, Bengaluru Express Pharma

Immuneel Therapeutics launches low cost treatment for blood cancer - drugscontrol.org

Immuneel Therapeutics launches low cost treatment for blood cancer drugscontrol.org

Biotech startup Immuneel Therapeutics raised $15 million in Series A round of funding led by Eight Roads - Startup Story

Biotech startup Immuneel Therapeutics raised $15 million in Series A round of funding led by Eight Roads Startup Story

Immuneel Therapeutics presents early data from India for Varnimcabtagene autoleucel at ASH Annual Meeting 2022 - Express Pharma

Immuneel Therapeutics presents early data from India for Varnimcabtagene autoleucel at ASH Annual Meeting 2022 Express Pharma

Immuneel, HCB and IDIBAPS enter into a collaboration and licensing agreement for CAR T cell therapy - Express Pharma

Immuneel, HCB and IDIBAPS enter into a collaboration and licensing agreement for CAR T cell therapy Express Pharma

Top Immuneel Therapeutics Pvt. Ltd. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant